Association between immune checkpoint inhibitor medication and uveitis: a population-based cohort study utilizing TriNetX database

Abstract

A significantly increased risk for uveitis diseases was found among the ICI group from the first year of follow-up. Increased awareness should be promoted on the occurrence of uveitis among cancer patients receiving ICI therapy.